Endocrinology, Vol 130, 437-442, Copyright © 1992 by Endocrine Society

ARTICLES

Effect of macrophage colony-stimulating factor on in vitro osteoclast generation and bone resorption

VA Corboz, MG Cecchini, R Felix, H Fleisch, G van der Pluijm and CW Lowik
Department of Pathophysiology, University of Berne, Switzerland.

To investigate the role of recombinant human macrophage colony- stimulating factor (rhM-CSF) on in vitro bone resorption, two bone explants, each at a different developmental stage, were adopted, namely 1) radii and 2) metatarsals of 17-day-old embryonic mice. At this stage of gestation, bone resorption in the radii is exclusively dependent upon fusion of osteoclast precursors and activation of mature osteoclasts, whereas in metatarsals it is dependent upon the generation of new osteoclasts. rhM-CSF showed no effect in radii, but stimulated 45Ca release in metatarsals, when they were either intact or periosteum stripped in coculture with embryonal liver as a source of hemopoietic progenitors. The rhM-CSF-induced increase in 45Ca release was paralleled by a higher number of osteoclasts. The stimulating effect was found to be in a concentration range between 250-500 U/ml M-CSF. The action of rhM-CSF was blocked by irradiation, indicating that it is dependent upon cell proliferation. These results, thus, show that M-CSF stimulates bone resorption only when it is dependent on generation of new osteoclasts. M-CSF does not appear to have any effect on the activity of mature osteoclasts. The mechanism of action might be direct on osteoclast precursors or indirect on accessory cells influencing osteoclast generation.

This article has been cited by other articles:

				K. Henriksen, M. Karsdal, J.-M. Delaisse, and M. T. Engsig RANKL and Vascular Endothelial Growth Factor (VEGF) Induce Osteoclast Chemotaxis through an ERK1/2-dependent Mechanism J. Biol. Chem., December 5, 2003; 278(49): 48745 - 48753. [Abstract] [Full Text] [PDF]

				G.-Q. Yao, J.-J. Wu, B.-H. Sun, N. Troiano, M. A. Mitnick, and K. Insogna The Cell Surface Form of Colony-Stimulating Factor-1 Is Biologically Active in Bone in Vivo Endocrinology, August 1, 2003; 144(8): 3677 - 3682. [Abstract] [Full Text] [PDF]

				K. L. Bost, J. L. Bento, J. K. Ellington, I. Marriott, and M. C. Hudson Induction of Colony-Stimulating Factor Expression following Staphylococcus or Salmonella Interaction with Mouse or Human Osteoblasts Infect. Immun., September 1, 2000; 68(9): 5075 - 5083. [Abstract] [Full Text] [PDF]

				G.-Q. Yao, B.-h. Sun, K. L. Insogna, and E. C. Weir Nuclear Factor-{kappa}B p50 Is Required for Tumor Necrosis Factor-{alpha}-Induced Colony-Stimulating Factor-1 Gene Expression in Osteoblasts Endocrinology, August 1, 2000; 141(8): 2914 - 2922. [Abstract] [Full Text] [PDF]

				T Laitala-Leinonen, C Lowik, S Papapoulos, and H. Vaananen Inhibition of intravacuolar acidification by antisense RNA decreases osteoclast differentiation and bone resorption in vitro J. Cell Sci., January 11, 1999; 112(21): 3657 - 3666. [Abstract] [PDF]

				K. A. Kelly, S. Tanaka, R. Baron, and J. M. Gimble Murine Bone Marrow Stromally Derived BMS2 Adipocytes Support Differentiation and Function of Osteoclast-Like Cells in Vitro Endocrinology, April 1, 1998; 139(4): 2092 - 2101. [Abstract] [Full Text] [PDF]

				G.-Q. Yao, B.-h. Sun, E. E. Hammond, E. N. Spencer, M. C. Horowitz, K. L. Insogna, and E. C. Weir The Cell-surface Form of Colony-stimulating Factor-1 Is Regulated by Osteotropic Agents and Supports Formation of Multinucleated Osteoclast-like Cells J. Biol. Chem., February 13, 1998; 273(7): 4119 - 4128. [Abstract] [Full Text] [PDF]